Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Targeted Genetics receives patent coverage for cellular therapy platform

Nov. 2, 1998

Senetek licenses autoinjectable drug delivery system to ICN

Oct. 29, 1998

IDEA licenses drug delivery technology to Procter & Gamble

Oct. 28, 1998

CE Mark approval granted for AastromReplicell system components

Oct. 28, 1998

Baxter, Inhale will seek partner to continue development of drug candidate

Oct. 28, 1998

ThromboSol prolongs cryopreservation of rhTPO-stimulated platelets in in vitro study

Oct. 27, 1998

Phase I studies establish feasibility, tolerability of oral delivery of heparin

Oct. 26, 1998

Endorex/Elan joint venture to develop Medipad-based drugs

Oct. 26, 1998

First high-affinity, nonpeptide BB1, BB2 receptor antagonists designed at Parke-Davis

Oct. 26, 1998

Millennium BioTherapeutics to use Abgenix human antibody technology

Oct. 21, 1998

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...